1. Dexmedetomidine administration is associated with improved outcomes in critically ill patients with acute myocardial infarction partly through its anti-inflammatory activity
   Yimou Liu et al, 2024, Frontiers in Pharmacology CrossRef
2. Brown adipose tissue-derived FGF21 mediates the cardioprotection of dexmedetomidine in myocardial ischemia/reperfusion injury
   Yi Ding et al, 2024, Scientific Reports CrossRef
3. Prevention of Reperfusion Injury in Acute Myocardial Infarction: A “flashback” Journey of Novel Strategies Based on the Potential Therapeutic Role of Antioxidants
   Francisco Salazar-Cornejo et al, 2023, Blood Oxidant Ties: The Evolving Concepts in Myocardial Injury and Cardiovascular Disease CrossRef
4. Insight into Cardioprotective Effects and Mechanisms of Dexmedetomidine
   Leyu Jiang et al, 2024, Cardiovascular Drugs and Therapy CrossRef